Alnylam Pharmaceuticals
ALNY
#814
Rank
HK$248.70 B
Marketcap
HK$1,859
Share price
0.23%
Change (1 day)
-46.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company